Precision medicine engaging nucleoside analogues: New advances to a conventional arsenal
Author:
- 11 April 2024
- journal article
- research article
- Published by Springer Nature in Advances in Traditional Medicine
- Vol. 25 (1) , 27-37
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Cytidine deaminase enzyme activity is a predictive biomarker in gemcitabine-treated cancer patientsCancer Chemotherapy and Pharmacology, 2023
- Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesCancer Chemotherapy and Pharmacology, 2023
- Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?European Journal of Drug Metabolism and Pharmacokinetics, 2022
- Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug ActionClinical Pharmacokinetics, 2020
- The powerful world of antisense oligonucleotides: From bench to bedsideWIREs RNA, 2020
- Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary InterventionCardiovascular Drugs and Therapy, 2020
- The Relation of the Chronic Disease Epidemic to the Health Care CrisisACR Open Rheumatology, 2020
- Hope and challenge: Precision medicine in bladder cancerCancer Medicine, 2019
- The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffoldAntiviral Research, 2018
- Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemiaPediatric Blood & Cancer, 2015